Non ST Segment Elevation Myocardial Infarction (NSTEMI)

DBCOND0045439Cardiovascular Diseases Signs, Symptoms, and General Pathologies

Non ST Segment Elevation Myocardial Infarction (NSTEMI) is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as: Non-ST-Segment-Elevation MI · NSTEMI · Non STEMI · Non-ST-Elevation Myocardial Infarction · Non ST Elevation Myocardial Infarction (NSTEMI)
Classified under: Cardiovascular Diseases
Signs, Symptoms, and General Pathologies
Indicated drugs: Clopidogrel
Fondaparinux
Tirofiban

Resolves to

Vocabularies

MeSHM000617720ICD-10I21SNOMED CT194811003MedDRA10000891UMLSC0155626

What you can answer from here — as of November 07, 2026

3Indicated drugsWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

91Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Non ST Segment Elevation Myocardial Infarction (NSTEMI) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account